In response to the recent U.S. Food and Drug Administration (FDA)’s announcement regarding flavored e-cigarettes and other tobacco products, the American Lung Association’s Senior Director of Advocacy, JoAnna Strother, issued the following statement:
“FDA clearly missed an opportunity to take meaningful action by punting on any decisions regarding the most prominent e-cigarettes with the largest market share. These products are marketed to our youth and are popular among youth. The FDA’s failure makes it clear that local protections are needed.
“When the federal government fails to protect our youth and our communities, we need our state and local elected officials to act to protect the health of Denver’s youth. The time for protective action is now. Every day that these extremely addictive products remain on the market our youth and communities are at risk.
The most commonly used products like Juul and Vuse will continue to be sold in Denver because FDA has so far failed to follow the science and order these products removed from the market.
“Denver’s kids need protective laws today. The Lung Association urges Denver City Council to take action and end the sale of all flavored tobacco products, including menthol cigarettes.”
For media interested in speaking with an expert, contact the American Lung Association at [email protected] or at 312-445-2501.
About the American Lung Association
The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy and research. The work of the American Lung Association is focused on four strategic imperatives: to defeat lung cancer; to champion clean air for all; to improve the quality of life for those with lung disease and their families; and to create a tobacco-free future. For more information about the American Lung Association, a holder of the coveted 4-star rating from Charity Navigator and a Gold-Level GuideStar Member, or to support the work it does, call 1-800-LUNGUSA (1-800-586-4872) or visit: Lung.org.